Dermal Fillers Market Overview and Introduction

Global Dermal Fillers Market is anticipated to grow at a 6.5% CAGR from 2019 to 2030

Dermal fillers are form of tissue-fillers which are injected underneath the skin to smooth lines & wrinkles, enhance facial contour, restore volume loss and soften of creases among others. In the US, it is estimated that more than 1 million females and males undergo dermal fillers assisted face rejuvenation treatment, every year. Facial treatment by means of dermal fillers, requires no surgery and proves to be a cost-effective treatment option for patients.

The global market is driven by increasing awareness regarding anti-aging, & other aesthetic treatments and improved acceptance of medical aesthetic therapies. Moreover, increasing preference of minimally invasive treatments, rising geriatric population, rise in medical tourism for aesthetics treatment, technological advancements & introduction of new cost effective products have been pivotal in contributing to the extensive growth of the global market. However, complications and risks associated with dermal filler treatment is likely to restrain the market to a certain extent.

Dermal Fillers Market by Product

On the basis of product, this market is segmented into biodegradable and non-biodegradable. The biodegradable segment is estimated to account for the largest share in the global market. The large share of this product can be attributed to increasing adoption of biodegradable hyaluronic acid as a dermal filler agent for several aesthetic treatments.

Dermal Fillers Market by Material

On the basis of material, the market can be segmented into calcium hydroxylapatite, collagen, PMMA, hyaluronic acid, poly-L-lactic acid, fat and other materials. In terms of market share, the segment of multiplatform is estimated to account for the largest market share, owing to increasing adoption of hyaluronic acid dermal filler for performing aesthetic treatments annually. According to International Society of Aesthetic Plastic Surgery (ISAPS), the total number hyaluronic acid dermal filler procedures performed in 2016, was estimated to be 3,372,445. Growing adoption of hyaluronic acid, is estimated to further rise in the coming years.

Dermal Fillers Market by Application

Similarly, in terms of application this market can be segmented into facial line correction treatment, scar treatment, lip enhancement and other applications. The segment of facial line correction treatment is estimated to grow at a robust CAGR during the forecast period, owing to growing focus on appearance among the population Based on the end users, the market is segmented into hospitals, dermatology clinics, ambulatory surgical centers and medical spas. The hospitals segment is estimated to account for the largest share of the global market. The large share of this segment can be attributed to presence of advanced facilities, availability of wide range of treatment options and highly skilled aesthetic professionals are likely to drive the growth of the segment.

Dermal Fillers Market by Regions

The global market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of dermal fillers, followed by Europe and Asia Pacific. North America will continue to dominate the global market in the forecast period owing to factors such increasing adoption of minimally invasive cosmetic procedures to improve overall physical appearance, availability of wide range of treatment options, and increasing adoption hyaluronic acid dermal fillers among others. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, Korea, Japan and India. Factors such as rise in medical tourism, low cost of aesthetic procedures and highly advanced hospital infrastructure are likely to attract patients from different parts of the world.

Dermal Fillers Market Prominent Players

The prominent players in the global market are Prollenium Medical Technologies, SCULPT Luxury Dermal Fillers LTD, DR. Korman, Anika Therapeutics, Inc., Bioxis pharmaceuticals, BioPlus Co., Ltd., Nestle Skin Health (Galderma laboratories), MERZ PHARMACEUTICALS, Sinclair Pharma, Allergan plc among others.